BioFire Diagnostics has filed a 510(k) clearance application with the FDA for a device that can screen positive blood cultures simultaneously for about 90% of the yeast microbes and gram-positive or gram-negative bacteria tied to bloodstream infections. The FilmArray Blood Culture Identification, or BCID, system could be released in the summer if cleared by the FDA.
BioFire seeks FDA clearance for blood culture ID system
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||